Platform

QPMind’s vision is to build an organically growing QSP model base that can be applied to all aspects of drug discovery and development to reduce the cost and increase the success rate of drugs in the clinic by a factor of five. The growing model base combined with AI and experts in the field acts as a “supermind” for drug discovery, delivering an efficiency like no prior approach.

QPMind’s growing QSP models make up disease models for neurodegenerative diseases and CNS disorders. The development of the models underlying this platform include the 20 years of modeling of In Silico Biosciences, and the application of generative AI and machine learning to suggest model structures and identify parameters for models using data sources from the open literature, ISB’s 20 year modeling history, and the pharmaceutical industry.